Biblio

Found 7 results

] Keyword Title Type Year

Filters: First Letter Of Last Name is O [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

O

R. F. Ozols and Vermorken, J. B., “Chemotherapy of advanced ovarian cancer: current status and future directions.”, Semin Oncol, vol. 24, no. 1 Suppl 2, pp. S2-1-S2-9, 1997.

R. F. Ozols, Markman, M., and Thigpen, J. T., “ICON3 and chemotherapy for ovarian cancer”, Lancet, vol. 360, pp. 2086-7; author reply 2088, 2002.

R. F. Ozols, Bundy, B. N., Greer, B. E., Fowler, J. M., Clarke-Pearson, D. L., Burger, R. A., Mannel, R., DeGeest, K., Hartenbach, E. M., Baergen, R., and Group, G. Oncology, “Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study”, J Clin Oncol, vol. 21, pp. 3194-200, 2003.

A. M. Oza, Cook, A. D., Pfisterer, J., Embleton, A. C., Ledermann, J. A., Pujade-Lauraine, E., Kristensen, G. B., Carey, M. S., Beale, P., Cervantes, A., Park-Simon, T. - W., Rustin, G. J. S., Joly, F., Mirza, M. R., Plante, M., Quinn, M., Poveda, A. M., Jayson, G. C., Stark, D., Swart, A. Marie, Farrelly, L., Kaplan, R. S., Parmar, M. K. B., and Perren, T. J., “Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial.”, Lancet Oncol, vol. 16, no. 8, p. 936, 2015.

R. Osborne, Filiaci, V. L., J, S., Mannel, R., Lage, J., A, A. - S., J, K., Provencher, D. M., Schilder, R. J., and Miller, D. S., “A randomized phase III trial comparing weekly parenteral methotrexate and "pulsed" dactinomycin as primary management for low-risk gestational trophoblastic neoplasia. ”, Society Gynecologic Oncologists, 2008.

A. Okamoto, Glasspool, R. M., Mabuchi, S., Matsumura, N., Nomura, H., Itamochi, H., Takano, M., Takano, T., Susumu, N., Aoki, D., Konishi, I., Covens, A., Ledermann, J. A., Mezzanzanica, D., Mezzazanica, D., Steer, C., Millan, D., McNeish, I. A., Pfisterer, J., Kang, S., Gladieff, L., Bryce, J., and Oza, A. M., “Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the ovary.”, Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S20-5, 2014.

M. Okadome, Saito, T., Tanaka, H., Nogawa, T., Furuta, R., Watanabe, K., Kita, T., Yamamoto, K., Mikami, M., Takizawa, K., and Group, J. Gynecologi, “Potential impact of combined high- and low-risk human papillomavirus infection on the progression of cervical intraepithelial neoplasia 2”, J Obstet Gynaecol Res, vol. 40, pp. 561-9, 2014.